<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Salimi H</submitter><funding>U.S. National Institutes of Health/NIAID</funding><funding>Iranian Ministry of Health and Medical Education</funding><funding>NIAID NIH HHS</funding><funding>Sir Zelman Cowen Fellowship Fund, Burnet Institute</funding><funding>NHMRC</funding><funding>Sir Zelman Cowen Senior Research Fellow</funding><funding>Australian NHMRC Early Career Research Fellowship</funding><funding>Australian NHMRC Level 2 Biomedical Career Development Award</funding><pagination>113-26</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3525831</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>93(1)</volume><pubmed_abstract>BR-derived HIV-1 strains have an exceptional ability to enter macrophages via mechanisms involving their gp120 Env that remain incompletely understood. Here, we used cell-based affinity-profiling methods and mathematical modeling to generate quantitative VERSA metrics that simultaneously measure Env-CD4 and Env-CCR5 interactions. These metrics were analyzed to distinguish the phenotypes of M-tropic and non-M-tropic CCR5-using HIV-1 variants derived from autopsy BRs and LNs, respectively. We show that highly M-tropic Env variants derived from brain can be defined by two distinct and simultaneously occurring phenotypes. First, BR-derived Envs demonstrated an enhanced ability to interact with CD4 compared with LN-derived Envs, permitting entry into cells expressing scant levels of CD4. Second</pubmed_abstract><journal>Journal of leukocyte biology</journal><pubmed_title>Macrophage-tropic HIV-1 variants from brain demonstrate alterations in the way gp120 engages both CD4 and CCR5.</pubmed_title><pmcid>PMC3525831</pmcid><funding_grant_id>R21 AI092218</funding_grant_id><funding_grant_id>#603708</funding_grant_id><funding_grant_id>#1006534</funding_grant_id><pubmed_authors>Chikere K</pubmed_authors><pubmed_authors>Lee B</pubmed_authors><pubmed_authors>Gray LR</pubmed_authors><pubmed_authors>Ellett A</pubmed_authors><pubmed_authors>Ramsland PA</pubmed_authors><pubmed_authors>Churchill MJ</pubmed_authors><pubmed_authors>Sterjovski J</pubmed_authors><pubmed_authors>Wesselingh SL</pubmed_authors><pubmed_authors>Salimi H</pubmed_authors><pubmed_authors>Roche M</pubmed_authors><pubmed_authors>Gorry PR</pubmed_authors><pubmed_authors>Webb N</pubmed_authors></additional><is_claimable>false</is_claimable><name>Macrophage-tropic HIV-1 variants from brain demonstrate alterations in the way gp120 engages both CD4 and CCR5.</name><description>BR-derived HIV-1 strains have an exceptional ability to enter macrophages via mechanisms involving their gp120 Env that remain incompletely understood. Here, we used cell-based affinity-profiling methods and mathematical modeling to generate quantitative VERSA metrics that simultaneously measure Env-CD4 and Env-CCR5 interactions. These metrics were analyzed to distinguish the phenotypes of M-tropic and non-M-tropic CCR5-using HIV-1 variants derived from autopsy BRs and LNs, respectively. We show that highly M-tropic Env variants derived from brain can be defined by two distinct and simultaneously occurring phenotypes. First, BR-derived Envs demonstrated an enhanced ability to interact with CD4 compared with LN-derived Envs, permitting entry into cells expressing scant levels of CD4. Second</description><dates><release>2013-01-01T00:00:00Z</release><publication>2013 Jan</publication><modification>2026-05-05T16:59:23.688Z</modification><creation>2026-04-07T21:52:04.411Z</creation></dates><accession>S-EPMC3525831</accession><cross_references><pubmed>23077246</pubmed><doi>10.1189/jlb.0612308</doi></cross_references></HashMap>